Overview

A Study of CAR-T Cells Targeting Autoimmune Diseases

Status:
NOT_YET_RECRUITING
Trial end date:
2028-06-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in patients with autoimmune disease.
Phase:
NA
Details
Lead Sponsor:
Beijing Boren Hospital